The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 29, 2020

Filed:

Mar. 04, 2016
Applicant:

Dana-farber Cancer Institute, Inc., Boston, MA (US);

Inventors:

Nathanael Gray, Boston, MA (US);

Tinghu Zhang, Brookline, MA (US);

Hai-Tsang Huang, Boston, MA (US);

Yubao Wang, Newton, MA (US);

Jean Zhao, Brookline, MA (US);

Hwan Geun Choi, Seoul, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 31/55 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 223/16 (2006.01); C07D 403/14 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01); C07D 231/12 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); A61K 31/337 (2013.01); A61K 31/55 (2013.01); A61P 35/00 (2018.01); C07D 223/16 (2013.01); C07D 231/12 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 413/12 (2013.01);
Abstract

Provided herein are small molecule inhibitors of maternal embryonic leucine zipper kinase (MELK) having the structure of formula (I), wherein X and R-Rare defined in the specification. The compounds are useful for treating cancer and other conditions or diseases associated with aberrant MELK expression. Also provided herein are pharmaceutical compositions comprising a compound of formula (I) and a pharmaceutically acceptable carrier. The invention also provides methods of treating cancers associated with over-expression of MELK.


Find Patent Forward Citations

Loading…